TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
69 hedge funds and large institutions have $4.17M invested in Tvardi Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-10
Holders Change %
-12.66%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
34
Closed
16
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$14K
Top Buyers
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$29.2K |
| 2 |
Renaissance Technologies
New York
|
+$13.3K |
| 3 |
FWCM
Ferguson Wellman Capital Management
Portland,
Oregon
|
+$10.7K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.1K |
| 5 |
C
Certuity
North Palm Beach,
Florida
|
+$3.91K |
Top Sellers
| 1 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$253K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$152K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$107K |
| 4 |
Goldman Sachs
New York
|
-$101K |
| 5 |
Jane Street
New York
|
-$99.5K |
